Inovio Pharmaceuticals


Kansas City MO Clinical Investigator Overseeing Two Vaccines Including Moderna’s mRNA-1273

A Kansas City, Missouri-based clinical investigational site is working overtime during the COVID-19 pandemic, which is quite the opposite for many research sites that saw their work with sponsors crawl to a halt during the slow downs.  Alliance for Multispecialty...

COVID-19 Vaccine INO-4800 Demonstrates Neutralizing Antibody and T-Cell Immune Responses in Preclinical Models

Inovio Pharmaceuticals (Nasdaq: INO) reported recent preclinical data summaries for their COVID-19 DNA vaccine called INO-4800 demonstrating promising information. Namely, the sponsor’s tests demonstrated robust neutralizing antibody and T cell immune responses...

Pin It on Pinterest